Therapeutics

Rezo Therapeutics Appoints Cristiana Guiducci, Ph.D., as Chief Scientific Officer

July 25, 2024

Eric Adam Joins HAYA Therapeutics as Chief Operating Officer

July 25, 2024

GRO Biosciences Secures $60.3M in Series B Financing to Advance Protein Therapeutics

July 24, 2024

Rondo Therapeutics Appoints Steven James to Board of Directors

July 11, 2024

Beacon Therapeutics Secures $170 Million in Series B Funding

July 9, 2024

Carisma Therapeutics Appoints Marella Thorell and David Scadden to Board of Directors

July 9, 2024

Curie.Bio Closes $380M Fund to Boost Early-Stage Therapeutics

July 1, 2024

TwoStep Therapeutics Launches with $6.5M Seed Funding to Tackle Solid Tumors

June 28, 2024

MOMA Therapeutics Welcomes New Leadership Team Members

June 28, 2024

Seaport Therapeutics Expands Executive Team with Key Appointments

June 20, 2024